Cargando…

Reporting of harms outcomes: a comparison of journal publications with unpublished clinical study reports of orlistat trials

BACKGROUND: The quality of harms reporting in journal publications is often poor, which can impede the risk-benefit interpretation of a clinical trial. Clinical study reports can provide more reliable, complete, and informative data on harms compared to the corresponding journal publication. This ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hodkinson, Alex, Gamble, Carrol, Smith, Catrin Tudur
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4840982/ https://www.ncbi.nlm.nih.gov/pubmed/27103582 http://dx.doi.org/10.1186/s13063-016-1327-z

Ejemplares similares

Reporting of harms data in RCTs: a systematic review of empirical assessments against the CONSORT harms extension
por: Hodkinson, Alex, et al.
Publicado: (2013)

Indirect Comparisons: A Review of Reporting and Methodological Quality
por: Donegan, Sarah, et al.
Publicado: (2010)

Completeness of Reporting of Patient-Relevant Clinical Trial Outcomes: Comparison of Unpublished Clinical Study Reports with Publicly Available Data
por: Wieseler, Beate, et al.
Publicado: (2013)

Risk-proportionate clinical trial monitoring: an example approach from a non-commercial trials unit
por: Tudur Smith, Catrin, et al.
Publicado: (2014)

Information work with unpublished reports
por: Holloway, A H, et al.
Publicado: (1976)

Comparison of orlistat and orlistat plus metformin therapy between diabetic and nondiabetic groups
por: Gunay, Yasemin Emur, et al.
Publicado: (2023)

Interventions to improve recruitment and retention in clinical trials: a survey and workshop to assess current practice and future priorities
por: Bower, Peter, et al.
Publicado: (2014)

Unpublished but public microbial genomes with biotechnological relevance
por: Siezen, Roland J., et al.
Publicado: (2008)

Selective reporting bias of harm outcomes within studies: findings from a cohort of systematic reviews
por: Saini, Pooja, et al.
Publicado: (2014)

Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias — An Updated Review
por: Dwan, Kerry, et al.
Publicado: (2013)

An Unpublished Bronze Écorché
por: Streeter, Edward C.
Publicado: (1917)

Conclusion of Unpublished Investigations
por: Rabuteau,
Publicado: (1869)

A comparison of interventional clinical trials in rare versus non-rare diseases: an analysis of ClinicalTrials.gov
por: Bell, Stuart A, et al.
Publicado: (2014)

Benefits and harms of the human papillomavirus (HPV) vaccines: comparison of trial data from clinical study reports with corresponding trial register entries and journal publications
por: Jørgensen, Lars, et al.
Publicado: (2020)

Application and investigation of a bound for outcome reporting bias
por: Williamson, Paula R, et al.
Publicado: (2007)

Obesity management: Update on orlistat
por: Drew, Belinda S, et al.
Publicado: (2007)

The Use of Orlistat in an Adult with Lipoprotein Lipase Deficiency: A Case Report
por: Jarrett, Zachary S., et al.
Publicado: (2021)

Selective reporting of outcomes in randomised controlled trials in systematic reviews of cystic fibrosis
por: Dwan, Kerry, et al.
Publicado: (2013)

Micropublication: incentivizing community curation and placing unpublished data into the public domain
por: Raciti, Daniela, et al.
Publicado: (2018)

Evidence base for patient and public involvement in clinical trials (EPIC)
por: Gamble, Carrol, et al.
Publicado: (2013)

Guidance to detect, evaluate and prevent the problem of selective reporting in trial publications
por: Dwan, Kerry, et al.
Publicado: (2013)

Visualising harms in publications of randomised controlled trials: consensus and recommendations
por: Phillips, Rachel, et al.
Publicado: (2022)

Orlistat in the prevention of diabetes in the obese patient
por: Mancini, Marcio C, et al.
Publicado: (2008)

Macrocytic Anemia and Thrombocytopenia Induced by Orlistat
por: Palacios-Martinez, David, et al.
Publicado: (2013)

Acute oxalate nephropathy associated with orlistat
por: Humayun, Youshay, et al.
Publicado: (2016)

Anti-epileptic drug harms: issues for meta-analysis
por: Smith, Catrin Tudur, et al.
Publicado: (2011)

Access to unpublished protocols and statistical analysis plans of randomised trials
por: Campbell, David, et al.
Publicado: (2022)

Assessment of Adverse Events in Protocols, Clinical Study Reports, and Published Papers of Trials of Orlistat: A Document Analysis
por: Schroll, Jeppe Bennekou, et al.
Publicado: (2016)

A mapping and gapping analysis of patient and public involvement in a clinical trials unit
por: Bagley, Heather, et al.
Publicado: (2013)

Unpublished manuscripts: from 1951 to 2007
por: Hörmander, Lars
Publicado: (2018)

Elizabeth Gaskell and mesmerism: an unpublished letter.
por: Hilton, C
Publicado: (1995)

Kurt Godel: unpublished philosophical essays
por: Kurt, Godel, et al.
Publicado: (1995)

Unpublished genomic data–how to share?
por: Nanda, Shreeya, et al.
Publicado: (2014)

The Parasitology of Indian Malaria. Unpublished Information
Publicado: (1929)

An Unpublished Letter of Sir Thomas Browne
por: Moschcowitz, Eli
Publicado: (1924)

Acute Oxalate Nephropathy Associated with Orlistat: A Case Report with a Review of the Literature
por: Chaudhari, Dhara, et al.
Publicado: (2013)

Training health professionals to recruit into challenging randomized controlled trials improved confidence: the development of the QuinteT randomized controlled trial recruitment training intervention
por: Mills, Nicola, et al.
Publicado: (2018)

Multiple treatment comparisons in epilepsy monotherapy trials
por: Tudur Smith, Catrin, et al.
Publicado: (2007)

The NIH public access policy did not harm biomedical journals
por: Peterson, A. Townsend, et al.
Publicado: (2019)

Abstracts in high profile journals often fail to report harm
por: Bernal-Delgado, Enrique, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_7bgttcsfd1guce64phip4pplka